• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hepatitis B viral infection with nephrotic syndrome treated with lamivudine.

作者信息

Banu N A, Khatoon S, Quadir E, Rahman M M, Khan M A

机构信息

Department of Pediatrics, Sir Salimullah Medical College, Mitford Hospital, Dhaka.

出版信息

Mymensingh Med J. 2007 Jul;16(2):230-3.

PMID:17703166
Abstract

A 04 years old boy with 02 months history of generalized oedema and scanty micturition was diagnosed as nephrotic syndrome with hepatitis B viral infection. He had evidence of active viral replication. After 01 month treatment with oral lamivudine, his urine became protein free and after 04 months, he had seroconversion from HBeAg+ve to HBeAg-ve. Lamivudine was continued for 01 year. He had no relapse after discontinuation of therapy and remained well after 36 months of completion of therapy. He had no evidence of active viral replication during this period, however HBsAg remained positive indication carrier state. As most children with HBV associated nephropathy have no evidence of chronic hepatitis, all such children must undergo HBV screening and for chronic liver disease if HBV screening is positive. As such children do not respond to prednisolone or other immunosuppresive therapy which might harm them, antiviral therapy should be considered. Lamivudine is a suitable alternative to IFN alpha owing to its low cost, ease of administration and fewer side effects.

摘要

相似文献

1
Hepatitis B viral infection with nephrotic syndrome treated with lamivudine.
Mymensingh Med J. 2007 Jul;16(2):230-3.
2
HBV associated nephrotic syndrome: resolution with oral lamivudine.乙型肝炎病毒相关肾病综合征:口服拉米夫定后病情缓解
Arch Dis Child. 2003 May;88(5):446-9. doi: 10.1136/adc.88.5.446.
3
Successful treatment of hepatitis B virus associated nephrotic syndrome with oral Lamivudine in a Nigerian child: a case report.尼日利亚儿童口服拉米夫定成功治疗乙型肝炎病毒相关性肾病综合征:一例报告。
J Trop Pediatr. 2012 Apr;58(2):157-8. doi: 10.1093/tropej/fmr046. Epub 2011 May 30.
4
Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection.拉米夫定用于治疗与乙型肝炎病毒(HBV)感染相关的肾病综合征。
Clin Nephrol. 2006 Mar;65(3):208-10. doi: 10.5414/cnp65208.
5
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.拉米夫定治疗化疗引起的乙型肝炎病毒感染再激活。
Am J Gastroenterol. 1999 Jan;94(1):249-51. doi: 10.1111/j.1572-0241.1999.00808.x.
6
Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.拉米夫定延长疗程再治疗慢性乙型肝炎:治疗中断后病毒抑制的维持情况
Hepatology. 1999 Oct;30(4):1082-7. doi: 10.1002/hep.510300427.
7
Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.拉米夫定治疗肝移植术后新发乙型肝炎感染的临床影响及疗效
Liver Transpl. 2002 Oct;8(10):892-900. doi: 10.1053/jlts.2002.35555.
8
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea.在韩国,慢性乙型肝炎患者接受拉米夫定治疗后乙肝e抗原血清学转换并不持久。
Hepatology. 2000 Oct;32(4 Pt 1):803-6. doi: 10.1053/jhep.2000.16665.
9
Effect of long-term lamivudine in chronic hepatitis B virus-infected children.长期使用拉米夫定对慢性乙型肝炎病毒感染儿童的影响。
Antivir Ther. 2004 Oct;9(5):729-32.
10
Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.乙肝表面抗原阳性患者肾移植或心脏移植后因肝炎发作停用拉米夫定治疗:一项回顾性病例系列研究
Clin Ther. 2006 Sep;28(9):1327-34. doi: 10.1016/j.clinthera.2006.09.011.